Literature DB >> 6441246

Natural killer (NK) cell activity of peripheral blood lymphocytes from patients with Bechterew's syndrome (ankylosing spondylitis).

O Vinje, O Førre, M Degre, P Møller.   

Abstract

Sixteen patients with Bechterew's syndrome (ankylosing spondylitis, AS) were investigated. All except one of the patients were HLA B27-positive. Peripheral blood lymphocytes from the patients were examined for spontaneous cytotoxicity against 51Cr-labelled K562 target cells. The cytotoxicity index of the non-T lymphocytes was negatively correlated with the serum CRP concentration (Pearson's r = 0.613, p less than 0.02). This finding seems to be caused by an alteration of the natural killer (NK) cell activity of the non-T lymphocytes during the active phase of the disease and not due to serum factors. The activity of the non-T cell fraction was slightly but not significantly reduced in patients with high disease activity (CRP greater than 0.01 g/l) compared with normal controls, (14.6 +/- 2.8 g/l versus 20.4 +/- 2.4 g/l mean +/- SE; p less than 0.10) Serum IgG and IgA concentrations were increased (p less than 0.001 and p less than 0.05 respectively) Interferon caused normal augmentation in the NK cell activity in AS patients, and no correlation was found between serum gamma interferon titres and the NK cell activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6441246     DOI: 10.3109/03009748409111299

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  6 in total

1.  Phenotyping of peripheral blood mononuclear cells in patients with ankylosing spondylitis.

Authors:  F Mateicka; L Rauová; D Zlanay; J Rovenský
Journal:  Clin Rheumatol       Date:  1992-12       Impact factor: 2.980

Review 2.  Natural killer cells and autoimmunity.

Authors:  E Grunebaum; E Malatzky-Goshen; Y Shoenfeld
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

3.  Natural killer cell function in ankylosing spondylitis.

Authors:  D Wendling; E Racadot; M Guidet
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

4.  Phenotypes and spontaneous cell cytotoxicity of mononuclear cells from patients with seronegative spondyloarthropathies: ankylosing spondylitis, psoriatic arthropathy and pauciarticular juvenile chronic arthritis--analysis of mononuclear cells from peripheral blood, synovial fluid and synovial membranes.

Authors:  J Thoen; O Førre; K Waalen; J Pahle
Journal:  Clin Rheumatol       Date:  1988-03       Impact factor: 2.980

5.  Immunological variables and acute-phase reactants in patients with ankylosing spondylitis (Bechterew's syndrome) and their relatives.

Authors:  O Vinje; P Møller; J Mellbye
Journal:  Clin Rheumatol       Date:  1984-12       Impact factor: 2.980

6.  T lymphocytes in ankylosing spondylitis and the influence of sulphasalazine treatment.

Authors:  N Feltelius; R Hällgren; O Sjöberg
Journal:  Clin Rheumatol       Date:  1987-12       Impact factor: 2.980

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.